In this study, participants receiving ALA showed a marked reduction in the Neuropathy Symptoms Score compared to those who did not receive treatment, the patients treated with ALA reported an average time of 18.4 days for symptom relief (Pieralice et al., 2019)
JAMA 2021;325:140313.ArticlePubMedPMC 49
GO-3 Plus combines clinically researched pre-, pro-, and post-biotic ingredients, along with the antioxidant SolarPlast, into one supplement
The cost of bias: Why GLP-1 stigma is a risk you cant afford to ignore GLP-1 medications have changed the conversation on obesity
Compromised healing environments : Perhaps most intriguingly (and this is what catches my attention as a surgeon), BPC-157 appeared to promote healing even in situations where recovery was impaired, such as tissues affected by corticosteroid use or areas with very poor blood supply
May 1, 2012